SCHEMBL2723746

SCHEMBL2723746

Cc1cccc(N(CCNC(=O)Nc2ccccc2Br)Cc2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
RAB9A P51151 6/20 0.46
NPC1 O15118 5/20 0.46
HTT P42858 4/20 0.46
JAK2 O60674 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PAX8 Q06710 1/20 0.46
KMT2A Q03164 6/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
NR3C1 P04150 2/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2724077 0.93 MTNR1A (0.47) MTNR1AMTNR1BRAB9ANPC1HTT
SCHEMBL31679065 0.88 GFER (0.53) RAB9ANPC1HTTALDH1A1KMT2A
SCHEMBL6732278 0.88 GFER (0.53) RAB9ANPC1HTTALDH1A1KMT2A
SCHEMBL2724952 0.87 GFER (0.44) RAB9ANPC1HTTALDH1A1PAX8
Iodide SCHEMBL16906337 0.86 GFER (0.44) RAB9ANPC1HTTALDH1A1PAX8
SCHEMBL2727185 0.82 RAB9A (0.42) MTNR1AMTNR1BRAB9ANPC1HTT
SCHEMBL15313243 0.81 MAPT (0.49) RAB9ANPC1HTTJAK2ALDH1A1
SCHEMBL28324786 0.79 KMT2A (0.48) MTNR1AMTNR1BRAB9ANPC1HTT
SCHEMBL2723101 0.79 KMT2A (0.64) RAB9ANPC1HTTALDH1A1KMT2A
SCHEMBL2724960 0.78 KMT2A (0.51) MTNR1AMTNR1BRAB9ANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12403139-B2 Methods and compositions for prevention and treatment of cardiac hypertrophy UNIVERSITY OF HAWAII (US) 2025-09-02 US claimed
US-20240189303-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII 2024-06-13 US claimed
EP-3393462-B1 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA UNIV ARIZONA (US) 2023-02-01 EP claimed
US-20210069184-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2021-03-11 US claimed
US-20190192508-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2019-06-27 US claimed
US-20190008865-A1 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2019-01-10 US claimed
US-10137123-B2 Methods and compositions for prevention and treatment of cardiac hypertrophy UNIVERSITY OF HAWAII (US) 2018-11-27 US claimed
EP-3393462-A1 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA Arizona Board of Regents on behalf of the University of Arizona (US) 2018-10-31 EP claimed
US-20170231982-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII 2017-08-17 US claimed
WO-2017112693-A1 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2017-06-29 WO claimed
US-20150352105-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-12-10 US claimed
US-9084786-B2 Methods and compositions for prevention and treatmentof cardiac hypertrophy UNIVERSITY OF HAWAII (US) 2015-07-21 US claimed
US-20130274271-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENTOF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII (US) 2013-10-17 US claimed
US-12186314-B2 Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2025-01-07 US disclosed
EP-3348267-B1 TRPV1 INHIBITOR FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2024-01-10 EP disclosed
EP-3393462-B1 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA UNIV ARIZONA (US) 2023-02-01 EP disclosed
EP-2635281-B1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2018-03-14 EP disclosed
WO-2017112693-A1 COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2017-06-29 WO disclosed
EP-2635281-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY University Of Hawaii (US) 2013-09-11 EP disclosed
WO-2012061505-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII (US) 2012-05-10 WO disclosed